Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients

Fig. 6

Decision curve analysis (DCA) of the nomogram model. The model has a high net benefit and a wide range of threshold probabilities in predicting the risk of biochemical recurrence within five (A) and three years (B). “None” means that no individual receives treatment or intervention. “All” means that all patients are treated or intervened clinically. The DCA presents a reference for patients who make decisions according to their respective anticipations

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us